Can you discuss a specific adult patient who came to you with GI symptoms and confirmed Fabry Disease, in whom therapeutic intervention improved their GI manifestations and quality of life? Do you supplement enzyme-focused treatment—chaperone therapy or ERT—of Fabry with other pharmacologic therapy?
Presenter
Medical Director, Pediatric Neurogastroenterology Program
Instructor, Harvard Medical School
Mass General Hospital for Children
Boston, MA